Eyal Rubin
Overview
Eyal Rubin received an average of $742K in total compensation, including $256K in salary, at Protalix BioTherapeutics from 2019 to 2022.
2022Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
2021Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
2020Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
2019Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
Source: SEC filings on May 18, 2023, April 29, 2022, and April 15, 2020.
Related executives
We found ten more executives who work or worked at Protalix BioTherapeutics.
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Chief Development Officer
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
David Aviezer
Protalix BioTherapeutics